Literature DB >> 34188340

Corticosteroid Withdrawal after Complete Resection of Recurrent IgG4-Related Ophthalmic Disease.

Yuki Hamano1, Yoshiyuki Kitaguchi1, Kohji Nishida1,2.   

Abstract

Corticosteroids are the first-line treatment for immunoglobulin G4-related ophthalmic disease (IgG4-ROD). However, the therapeutic effect of corticosteroids is unpredictable, and recurrences occur frequently. We present a case of a 60-year-old woman with IgG4-ROD of the lacrimal fossa. She was first treated with oral prednisolone, which was tapered within three months. However, proptosis recurred two months after prednisolone withdrawal. En bloc excision of the lesion was performed via the eyelid crease approach. The patient is lesion-free without corticosteroids at 18 months after surgery. Complete resection can be a powerful strategy for IgG4-ROD if a well-defined lesion is located in accessible areas.
© 2020 Taylor & Francis Group, LLC.

Entities:  

Keywords:  Complete resection; IgG4-related ophthalmic disease; corticosteroid; recurrent lesion

Year:  2020        PMID: 34188340      PMCID: PMC8210864          DOI: 10.1080/01658107.2020.1729817

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  11 in total

1.  Predicting therapeutic response in IgG4-related disease based on cluster analysis.

Authors:  Motohisa Yamamoto; Ken-Ichi Takano; Ryuta Kamekura; Chisako Suzuki; Tetsuya Tabeya; Rieko Murakami; Saho Honda; Masaya Mukai; Masanori Nojima; Shingo Ichimiya; Tetsuo Himi; Hiroshi Nakase; Hiroki Takahashi
Journal:  Immunol Med       Date:  2018-04-03

2.  High serum IgG4 concentrations in patients with sclerosing pancreatitis.

Authors:  H Hamano; S Kawa; A Horiuchi; H Unno; N Furuya; T Akamatsu; M Fukushima; T Nikaido; K Nakayama; N Usuda; K Kiyosawa
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

3.  Location and frequency of lesions in patients with IgG4-related ophthalmic diseases.

Authors:  Yuka Sogabe; Koh-ichi Ohshima; Atsushi Azumi; Masayuki Takahira; Satoru Kase; Hideki Tsuji; Hiroshi Yoshikawa; Tetsuya Nakamura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-01-03       Impact factor: 3.117

4.  Tear production after unilateral removal of the main lacrimal gland in squirrel monkeys.

Authors:  D Y Maitchouk; R W Beuerman; T Ohta; M Stern; R J Varnell
Journal:  Arch Ophthalmol       Date:  2000-02

5.  Surgical debulking for idiopathic dacryoadenitis: a diagnosis and a cure.

Authors:  Ilse Mombaerts; J Douglas Cameron; Waruttaporn Chanlalit; James A Garrity
Journal:  Ophthalmology       Date:  2013-10-25       Impact factor: 12.079

6.  Orbital Involvement and Ocular Surface Changes in IgG4-Related Systemic Disease.

Authors:  Sibel Kocabeyoglu; Omer Karadag; Mehmet C Mocan; Abdulsamed Erden; Murat Irkec
Journal:  Cornea       Date:  2016-11       Impact factor: 2.651

7.  Standard steroid treatment for autoimmune pancreatitis.

Authors:  T Kamisawa; T Shimosegawa; K Okazaki; T Nishino; H Watanabe; A Kanno; F Okumura; T Nishikawa; K Kobayashi; T Ichiya; H Takatori; K Yamakita; K Kubota; H Hamano; K Okamura; K Hirano; T Ito; S B H Ko; M Omata
Journal:  Gut       Date:  2009-04-26       Impact factor: 23.059

8.  A prevalence study of IgG4-related ophthalmic disease in Japan.

Authors: 
Journal:  Jpn J Ophthalmol       Date:  2013-08-07       Impact factor: 2.447

Review 9.  Ocular adnexal lymphoproliferative lesions.

Authors:  T J Liesegang
Journal:  Mayo Clin Proc       Date:  1993-10       Impact factor: 7.616

10.  The natural course of IgG4-related ophthalmic disease after debulking surgery: a single-centre retrospective study.

Authors:  Jun Ominato; Tokuhide Oyama; Hiroyuki Cho; Naoya Shiozaki; Hajime Umezu; Jun Takizawa; Takeo Fukuchi
Journal:  BMJ Open Ophthalmol       Date:  2019-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.